RXi Pharmaceuticals Corporation Employee Directory
Biotechnology ResearchMassachusetts, United States11-50 Employees
RXi Pharmaceuticals Corporation is a biotechnology research company focused on developing immuno-oncology therapies guided by RNA interference. It is pursuing a self-delivering RNAi platform, including sd-rxRNA compounds, to create next-generation therapeutics. The company is based in Marlborough, Massachusetts, and maintains a relatively small team dedicated to advancing its research programs in this field. In the biotechnology sector, RXi aims to apply RNAi-based approaches to immuno-oncology. In 2024, the company announced that its scientists would present new data on the mechanism of RNAi compounds at Keystone Symposia, signaling ongoing R&D activity and engagement with the scientific community. The provided information does not specify customers or revenue, but it emphasizes ongoing research and collaboration in immuno-oncology.